AVALO THERAPEUTICS, INC. Public Float
AVALO THERAPEUTICS, INC. (AVTX) had Public Float of $53.70 million as of 2025-06-30, per its 10-K filed 2026-03-23.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-23
- 2025-06-30: Entity Public Float $53.70M.
- 2024-06-28: Entity Public Float $12.90M.
- 2023-06-30: Entity Public Float $4.80M.
- 2022-06-30: Entity Public Float $32.40M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $53.70M 10-K · filed 2026-03-23 |
| 2024-06-28 | $12.90M 10-K · filed 2025-03-20 |
| 2023-06-30 | $4.80M 10-K · filed 2024-03-29 |
| 2022-06-30 | $32.40M 10-K · filed 2023-03-29 |
| 2021-06-30 | $183.50M 10-K · filed 2022-03-02 |
| 2020-06-30 | $112.10M 10-K · filed 2021-03-08 |
| 2019-06-28 | $81.30M 10-K · filed 2020-03-11 |
| 2018-06-30 | $40.82M 10-K · filed 2019-03-18 |
| 2017-06-30 | $5.88M 10-K · filed 2018-04-02 |
| 2016-12-31 | $6.80M 10-K · filed 2017-03-14 |
| 2015-06-30 | $0.00 10-K · filed 2016-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |